• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

MS Sequencing: Part 1 – Mechanism of action of DMTs

November 3, 2016  

ECTRIMS 2016 SLIDE DECK

October 24, 2016  

Phase III results for siponimod in SPMS

September 28, 2016  

ECTRIMS DAILY REPORT – SATURDAY EDITION

September 17, 2016  

ECTRIMS DAILY REPORT – FRIDAY EDITION

September 16, 2016  

ECTRIMS DAILY REPORT – THURSDAY EDITION

September 15, 2016  

EMD Serono’s LAUNCH program – A model for academia/industry partnerships

September 7, 2016  

EDSS change an unreliable measure of progression

August 17, 2016  

Brain volume loss associated with cognitive decline in MS

July 27, 2016  

Relevance of assessing body weight in MS patients

June 8, 2016  
Previous
25
26
27
28
29
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions